AVR anteris technologies global corp.

Ann: DurAVR First In Human Patient 6 Month Study Follow Up, page-36

  1. 5,799 Posts.
    lightbulb Created with Sketch. 963
    Also adding to my comments - The final OK in respect to the implant would be patient/Doctor (obvious the latter most influence)- I would suspect 'salesmen/women' would be the last on the list of influence.

    Plus there are more and more top cardios.... becoming aware of AVR's valve and I am sure they would not want to use an 'inferior' product, when aware of AVR's. My understanding most top cardios... attend the top seminars ----- and who has been presenting AVR's lately -guess ? - presented by top cardios.

    So 'top' wins in my opinion.

    But you must do your own research.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$6.27
Change
0.360(6.09%)
Mkt cap ! $97.17M
Open High Low Value Volume
$5.93 $6.30 $5.91 $107.9K 17.39K

Buyers (Bids)

No. Vol. Price($)
1 3500 $6.12
 

Sellers (Offers)

Price($) Vol. No.
$6.27 200 1
View Market Depth
Last trade - 15.42pm 27/06/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.